A2F ASSOCIATES LIMITED -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 14.839.774 718.845 1
2017 0 5.934.086 301.870 1
2016 0 12.607.357 389.875 2
2015 0 5.913.080 142.282 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITY COLLEGE LONDON3
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
LUNDS UNIVERSITET2
SERVICIO MADRILENO DE SALUD2
ACADEMISCH ZIEKENHUIS LEIDEN1
ALPHA BIORESEARCH SL1
ASPHALION SL1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION1
BATAVIA BIOSCIENCES BV1
CARDIOR PHARMACEUTICALS1
CELLPROTECT NORDIC PHARMACEUTICALS AB1
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL1
EURAM LIMITED1
FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA1
FINVECTOR OY1
FINVECTOR VISION THERAPIES OY1
FUNDACIO CENTRE DE REGULACIO GENOMICA1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
GREAT ORMOND STREET HOSPITAL FOR CHILDREN NHS FOUNDATION TRUST1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INTOMICS AS1
KAROLINSKA INSTITUTET1
KING'S COLLEGE LONDON1
KLINIKUM DER UNIVERSITAET ZU KOELN1
KOBENHAVNS UNIVERSITET1
KUOPIO UNIVERSITY HOSPITAL1
MAST CARBON INTERNATION1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MEDIZINISCHE UNIVERSITAET WIEN1
MEDSCINET AB1
NORDIC HEALTH ECONOMICS AB1
POHJOISSAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
REGION HOVEDSTADEN1
SIRION BIOTECH1
SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH1
STICHTING VUMC1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE UNIVERSITY OF EDINBURGH1
UNIVERSITA DEGLI STUDI DI PADOVA1
UNIVERSITA DI PISA1
UNIVERSITAET BERN1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITE LIBRE DE BRUXELLES1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF BRIGHTON1
UNIVERSITY OF EASTERN FINLAND1
UNIVERSITY OF LEICESTER1
VRIJE UNIVERSITEIT BRUSSEL1
YAQRIT LIMITED1

Constancy:

Total number of partners: 56
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 53
Frequent / Rare Partner Ratio: 0.06

Project overview:

Start dateProjectacronymrolefundingpartners
2019-01-01CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease CardioReGenixparticipant14.839.77413
2017-01-01Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory anginaA phase II randomized, double-blinded, placebo-controlled study ReGenHeartparticipant5.934.0869
2016-01-01Boost Brittle Bones Before Birth BOOSTB4participant6.608.75513
2016-01-01Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes T2DSystemsparticipant5.998.60312
2015-05-01Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. CARBALIVEparticipant5.913.08014